Compare Definium Therapeutics Inc. Common Shares (DFTX) vs NIO Inc. (NIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs NIO Inc. — how do they compare? Definium Therapeutics Inc. Common Shares trades at $37 (market cap $4.59B), while NIO Inc. trades at $3.61 (market cap $8.62B). The key difference: NIO Inc. is the larger of the two by market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, NIO Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and NIO Inc. for 81 Days on average.
| DFTX | NIO | |
|---|---|---|
Market Cap | $4.59B | $8.62B |
Volume | 2,103,937 | 39,648,517 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.45 | $7.46 |
52-Week Low | $10.68 | $3.37 |
Typical Hold Time | 0 Days | 81 Days |
Enterprise Value | $3.55B | $6.52B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NIO trades at $3.54, up 1.72% today but near a 52-week low, with a bearish technical signal. Revenue grew to $87.49B in 2025, yet net losses persist at -$15.57B, though margins improved. Recent Q3 2026 deliveries rose 25.4%, and a strategic battery-swap partnership with Geely aims to expand network utilization, valued at $2.38B.
The outlook hinges on scaling profitability amid a brutal EV price war. Analysts see 76% upside to a $6.23 target, but high debt and cash burn pose risks. Sentiment is mixed, with news highlighting growth potential against competitive and macroeconomic headwinds in China.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About NIO Inc.
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →
